RLX Technology Inc., the leading electronic cigarette brand in China, announced that one of its subsidiaries has been awarded a manufacturing license by the State Tobacco Monopoly Administration of the People's Republic of China (STMA). This license allows for the production of Yooz brand e-cigarette charging devices, pods, and related products that comply with China's e-cigarette management regulations. The approved manufacturing capacity is 15,050,000 pod vapes yearly, 328,700,000 units of cigarettes yearly, and 6,100,000 disposable electronic vapor products yearly.
Over the last 12 months, RLX's stock price has declined by 65.60%. The one-year forecast for RLX Technology Inc.'s stock points to a potential upside of 80.93%. The average stock rating for RLX is currently 1.70, indicating a bullish outlook in the stock market.
The market capitalization of RLX reached $2.12 billion with 1.34 billion outstanding shares, and 443.55 million shares currently in circulation. In the past trading day, RLX had a trading volume of 3,707,012 shares, which is significantly higher than the average trading volume of 7.24 million shares and is one of the reasons why market regulators consider the stock to be active.
Wall Street experts' opinions on RLX Technology Inc. [RLX]:
According to Wall Street experts' analysis, the current consensus on the target price for RLX stock is $7.34 per share. Analysis of stock target prices and performance is typically closely studied by market experts. Currently, the consensus on RLX stock among Wall Street analysts is a recommendation set at 1.70. This rating represents a strong buy recommendation on a scale of 1 to 5, where 5 indicates a strong sell, 4 indicates a sell, 3 indicates a hold, and 2 indicates a buy.
Bank of America Securities has conducted an estimate on RLX Technology Inc.'s stocks and maintained a neutral view, the same recommendation as of November 1st, 2021. While these analysts kept their previous recommendation, Citigroup has raised its target price to buy. The new target price was announced on March 12th, 2021 and represents the official target price of RLX Technology Inc.'s stock. Prior to this, the target price was raised again to $30, and analysts at Huaxing Capital maintained a buy rating on RLX's stock.
The average ATR for RLX Technology Inc. is set at 0.11. The stock's market-to-sales ratio over the past 12 months is 1.84. The market-to-book ratio for the previous quarter was 0.94, and the price-to-cash ratio for the same quarter was 1.07 per share.
RLX stock performance analysis:
Last week, RLX Technology Inc. [RLX] dipped into the red zone, exhibiting a downward trend and dropping 4.76 points. With this latest performance, the company's stock has seen a 19.54% decrease in the past 4 weeks, a 53.64% decrease in the past 6 months, and a staggering 65.60% decrease over the past year.
The overbought and oversold stocks can be easily tracked through the Relative Strength Index (RSI), wherein an RSI result above 70 indicates overbought and any ratio below 30 represents an oversold situation. An RSI rate of 50 will represent a neutral market momentum. The current RSI setting for RLX stocks over the past two weeks is 33.08, with the last traded RSI reaching 28.09, while RLX Technology Inc.'s three-week RSI setting is at 36.66.
The current 50-day moving average for the stock [RLX] stands at 1.8510, with the past week's trading recorded at 1.4340, and the past 200-day average at 2.6911.
Gain a deeper understanding of the fundamentals of RLX Technology Inc.
The liquidity data of RLX Technology Inc. is also interesting and noteworthy, with a quick ratio of 4.90 and a current ratio of 5.00.
RLX stock earnings per share.
One way to track a company's progress is by looking at its EPS growth rate, and Wall Street analysts focus on predicting a company's 5-year EPS growth rate. In regards to the aforementioned value, analysts predict that RLX Technology Inc.'s 5-year earnings per share growth rate will reach 14.07%.
Insider job details at RLX Technology Inc. [RLX]
Currently, institutional investors hold approximately $386 million or 30.80% of RLX's stock. The top three institutional holders of RLX stock are IDG CHINA VENTURE CAPITAL FUND V ASSOCIATES LP, with 60,068,870 shares representing approximately 0% of the company's market value and 39.34% of total institutional holdings; WILDCAT CAPITAL MANAGEMENT, LLC with 30,893,022 shares valued at approximately $43.25 million; and APOLETTO LTD with current holdings of RLX stock valued at $40.11 million, representing almost 0% of the company's market value.
The holdings of RLX Technology Inc. [NYSE:RLX] increased by approximately 23,458,971 shares among 44 institutional investors. Additionally, 68 investors decreased their holdings by around 35,200,778 shares, while 23 investors reduced their holdings by 217,355,335 shares. According to the latest report from the US Securities and Exchange Commission, institutional holdings have now reached 276,015,084 shares. 22 new institutional investors have invested a total of 7,516,965 shares in RLX stock, while 20 institutional investors sold 9,770,681 shares during the same period.
Statement:
This article is compiled from third-party information and is intended for industry communication and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The translation of this article is solely for industry exchanges and research purposes.
Due to limitations in our translation capabilities, the compiled article may not express the exact same meaning as the original text. Please refer to the original text for accuracy.
2FIRSTS aligns its viewpoints and positions completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related issues.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
